

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 8.87078050 |
| 2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 8.23803468 |
| 3 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 8.23803468 |
| 4 | neutrophil mediated immunity (GO:0002446) | 8.17735103 |
| 5 | negative regulation of phagocytosis (GO:0050765) | 6.88919549 |
| 6 | myeloid leukocyte mediated immunity (GO:0002444) | 6.49936538 |
| 7 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 6.38039700 |
| 8 | killing of cells of other organism (GO:0031640) | 6.23455592 |
| 9 | disruption of cells of other organism (GO:0044364) | 6.23455592 |
| 10 | DNA deamination (GO:0045006) | 6.07866858 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 5.62256969 |
| 12 | * negative regulation of growth of symbiont in host (GO:0044130) | 5.30383843 |
| 13 | * negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.30383843 |
| 14 | * modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.30383843 |
| 15 | * regulation of growth of symbiont in host (GO:0044126) | 5.30383843 |
| 16 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.24188611 |
| 17 | negative regulation of interleukin-8 production (GO:0032717) | 5.22280989 |
| 18 | regulation of MHC class II biosynthetic process (GO:0045346) | 5.20066950 |
| 19 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.06210723 |
| 20 | microglial cell activation (GO:0001774) | 5.04662246 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 5.00563985 |
| 22 | cellular response to zinc ion (GO:0071294) | 4.90706088 |
| 23 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.88223622 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.83495981 |
| 25 | DNA strand elongation (GO:0022616) | 4.83417202 |
| 26 | response to peptidoglycan (GO:0032494) | 4.75796028 |
| 27 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.66166277 |
| 28 | leukocyte mediated cytotoxicity (GO:0001909) | 4.59578560 |
| 29 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.56089287 |
| 30 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.47865710 |
| 31 | cell wall macromolecule catabolic process (GO:0016998) | 4.38321011 |
| 32 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.35247574 |
| 33 | * response to fungus (GO:0009620) | 4.17710037 |
| 34 | telomere maintenance via recombination (GO:0000722) | 4.13730898 |
| 35 | DNA replication initiation (GO:0006270) | 4.04886646 |
| 36 | innate immune response in mucosa (GO:0002227) | 4.02723831 |
| 37 | nucleobase biosynthetic process (GO:0046112) | 3.94887534 |
| 38 | DNA unwinding involved in DNA replication (GO:0006268) | 3.93763070 |
| 39 | IMP metabolic process (GO:0046040) | 3.92908129 |
| 40 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.87561187 |
| 41 | glucose 6-phosphate metabolic process (GO:0051156) | 3.81414833 |
| 42 | cotranslational protein targeting to membrane (GO:0006613) | 3.79564045 |
| 43 | protein targeting to ER (GO:0045047) | 3.75861800 |
| 44 | mitotic recombination (GO:0006312) | 3.75586869 |
| 45 | centriole replication (GO:0007099) | 3.73470136 |
| 46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.70732540 |
| 47 | angiotensin maturation (GO:0002003) | 3.67837188 |
| 48 | protein localization to endoplasmic reticulum (GO:0070972) | 3.61800005 |
| 49 | IMP biosynthetic process (GO:0006188) | 3.61574011 |
| 50 | cell wall macromolecule metabolic process (GO:0044036) | 3.60445446 |
| 51 | DNA replication checkpoint (GO:0000076) | 3.59007232 |
| 52 | telomere maintenance via telomere lengthening (GO:0010833) | 3.57941082 |
| 53 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.56526360 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55794489 |
| 55 | L-fucose catabolic process (GO:0042355) | 3.53233775 |
| 56 | fucose catabolic process (GO:0019317) | 3.53233775 |
| 57 | L-fucose metabolic process (GO:0042354) | 3.53233775 |
| 58 | pentose-phosphate shunt (GO:0006098) | 3.51328224 |
| 59 | angiogenesis involved in wound healing (GO:0060055) | 3.50175566 |
| 60 | positive regulation of granulocyte differentiation (GO:0030854) | 3.49986350 |
| 61 | viral transcription (GO:0019083) | 3.48082112 |
| 62 | antibacterial humoral response (GO:0019731) | 3.44651516 |
| 63 | translational termination (GO:0006415) | 3.41370176 |
| 64 | pentose metabolic process (GO:0019321) | 3.36821015 |
| 65 | signal peptide processing (GO:0006465) | 3.36376354 |
| 66 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.34899235 |
| 67 | NADPH regeneration (GO:0006740) | 3.34716251 |
| 68 | regulation of phagocytosis (GO:0050764) | 3.32259725 |
| 69 | macrophage chemotaxis (GO:0048246) | 3.28805093 |
| 70 | * defense response to fungus (GO:0050832) | 3.28596634 |
| 71 | mannose metabolic process (GO:0006013) | 3.28028636 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 3.25454656 |
| 73 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.24626531 |
| 74 | cell killing (GO:0001906) | 3.24344511 |
| 75 | CENP-A containing nucleosome assembly (GO:0034080) | 3.23906724 |
| 76 | protein localization to kinetochore (GO:0034501) | 3.22618493 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.22241789 |
| 78 | deoxyribose phosphate catabolic process (GO:0046386) | 3.21020157 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20646746 |
| 80 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.18742316 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.18214017 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18214017 |
| 83 | deoxyribonucleotide catabolic process (GO:0009264) | 3.16767234 |
| 84 | antimicrobial humoral response (GO:0019730) | 3.16067729 |
| 85 | purine nucleobase biosynthetic process (GO:0009113) | 3.15085884 |
| 86 | translational elongation (GO:0006414) | 3.14416894 |
| 87 | negative regulation of chemokine production (GO:0032682) | 3.14063733 |
| 88 | chromatin remodeling at centromere (GO:0031055) | 3.12648277 |
| 89 | heme biosynthetic process (GO:0006783) | 3.12073249 |
| 90 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.09692597 |
| 91 | regulation of chemokine biosynthetic process (GO:0045073) | 3.08567121 |
| 92 | mucosal immune response (GO:0002385) | 3.07615167 |
| 93 | response to muramyl dipeptide (GO:0032495) | 3.06898774 |
| 94 | ribosomal small subunit biogenesis (GO:0042274) | 3.04424684 |
| 95 | pseudouridine synthesis (GO:0001522) | 3.03662003 |
| 96 | interaction with symbiont (GO:0051702) | 2.98978142 |
| 97 | regulation of B cell differentiation (GO:0045577) | 2.96453243 |
| 98 | auditory receptor cell differentiation (GO:0042491) | 2.95593529 |
| 99 | organ or tissue specific immune response (GO:0002251) | 2.94666635 |
| 100 | macrophage activation (GO:0042116) | 2.94600134 |
| 101 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.92631105 |
| 102 | maturation of SSU-rRNA (GO:0030490) | 2.91221115 |
| 103 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90802907 |
| 104 | leukotriene biosynthetic process (GO:0019370) | 2.90608752 |
| 105 | negative regulation of B cell apoptotic process (GO:0002903) | 2.90097799 |
| 106 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.89965716 |
| 107 | mast cell activation (GO:0045576) | 2.88594108 |
| 108 | pinocytosis (GO:0006907) | 2.88045599 |
| 109 | dosage compensation (GO:0007549) | 2.86951789 |
| 110 | UV protection (GO:0009650) | 2.83827356 |
| 111 | centriole assembly (GO:0098534) | 2.83054145 |
| 112 | regulation of female gonad development (GO:2000194) | 2.81259354 |
| 113 | glial cell migration (GO:0008347) | 2.78431527 |
| 114 | macrophage differentiation (GO:0030225) | 2.77842641 |
| 115 | leukocyte degranulation (GO:0043299) | 2.77253816 |
| 116 | induction of positive chemotaxis (GO:0050930) | 2.76085710 |
| 117 | hemoglobin metabolic process (GO:0020027) | 2.74572937 |
| 118 | intra-S DNA damage checkpoint (GO:0031573) | 2.73975428 |
| 119 | protein localization to chromosome, centromeric region (GO:0071459) | 2.72358055 |
| 120 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.72063591 |
| 121 | purine nucleobase metabolic process (GO:0006144) | 2.70982818 |
| 122 | base-excision repair, AP site formation (GO:0006285) | 2.70433879 |
| 123 | cellular protein complex disassembly (GO:0043624) | 2.70108906 |
| 124 | DNA topological change (GO:0006265) | 2.69812927 |
| 125 | heart process (GO:0003015) | 2.69138466 |
| 126 | heart contraction (GO:0060047) | 2.69138466 |
| 127 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.69087804 |
| 128 | definitive hemopoiesis (GO:0060216) | 2.68835342 |
| 129 | DNA replication-independent nucleosome organization (GO:0034724) | 2.68792614 |
| 130 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.68792614 |
| 131 | cellular response to exogenous dsRNA (GO:0071360) | 2.67769249 |
| 132 | defense response to bacterium (GO:0042742) | 2.67497531 |
| 133 | positive regulation of phagocytosis (GO:0050766) | 2.67324618 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.66351461 |
| 135 | necroptotic process (GO:0070266) | 2.65600259 |
| 136 | translational initiation (GO:0006413) | 2.65157522 |
| 137 | protein complex disassembly (GO:0043241) | 2.65026233 |
| 138 | mast cell activation involved in immune response (GO:0002279) | 2.64506001 |
| 139 | mast cell degranulation (GO:0043303) | 2.64506001 |
| 140 | kinetochore organization (GO:0051383) | 2.64264242 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.63982429 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63753156 |
| 143 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.63048665 |
| 144 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.62231113 |
| 145 | mitotic nuclear envelope disassembly (GO:0007077) | 2.61633510 |
| 146 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.60901028 |
| 147 | telomere maintenance (GO:0000723) | 2.60878434 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.60422279 |
| 149 | telomere organization (GO:0032200) | 2.58535806 |
| 150 | translation (GO:0006412) | 2.58279477 |
| 151 | translesion synthesis (GO:0019985) | 2.58252596 |
| 152 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.57577494 |
| 153 | formation of translation preinitiation complex (GO:0001731) | 2.57080340 |
| 154 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.55665024 |
| 155 | viral mRNA export from host cell nucleus (GO:0046784) | 2.53566106 |
| 156 | anterograde synaptic vesicle transport (GO:0048490) | 2.52568774 |
| 157 | modification by host of symbiont morphology or physiology (GO:0051851) | 2.51626829 |
| 158 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51350349 |
| 159 | rRNA processing (GO:0006364) | 2.50870455 |
| 160 | viral life cycle (GO:0019058) | 2.50601704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.63155510 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.91535652 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.38582693 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.26813847 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.07055036 |
| 6 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02841525 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.94385448 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85692517 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.74284331 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.59738208 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.57710695 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.56314237 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55949266 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.54552094 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.50861930 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.48675676 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42564843 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.28533538 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.27223752 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.26422121 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.24515942 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.23717163 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18778971 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10180391 |
| 25 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06254510 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04301424 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.01602099 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00719915 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98132231 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94831722 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94529319 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90982998 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90508604 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88391624 |
| 35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.85433121 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.85375151 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81813858 |
| 38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.80916893 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.79971680 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79093033 |
| 41 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72935158 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.72576105 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72369424 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69533768 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.67921940 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67711836 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66115916 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65620279 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65160005 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63634623 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62822601 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62416916 |
| 53 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.61675742 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60819970 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59888256 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57516212 |
| 57 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57369820 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55881378 |
| 59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54574715 |
| 60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.52313518 |
| 61 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50628568 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48947782 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.45720811 |
| 64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43185839 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42848731 |
| 66 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40403159 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.39931246 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38411774 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35337473 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35017986 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33562819 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32943152 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32744338 |
| 74 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31994413 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31075853 |
| 76 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30674605 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29586292 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28952660 |
| 79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28801634 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28726593 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28616930 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28395503 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24944425 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.24545278 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23083221 |
| 86 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22138156 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18054793 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16482157 |
| 89 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.16280594 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14580782 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14399747 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12595700 |
| 93 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12014763 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10668032 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10510339 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10127284 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 1.10014050 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09110929 |
| 99 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.08595077 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08327462 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08306449 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06937867 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06621033 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06215731 |
| 105 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05823331 |
| 106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05746281 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04254452 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03870966 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 1.03867009 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03455096 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02246500 |
| 112 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01538021 |
| 113 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01355428 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00509101 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99831089 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99723240 |
| 117 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.98890657 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98067988 |
| 119 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97617133 |
| 120 | MAF_26560356_Chip-Seq_TH1_Human | 0.96743815 |
| 121 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96720496 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95062073 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94648781 |
| 124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92419443 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90556721 |
| 126 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90407173 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88608295 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87923846 |
| 129 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87212886 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86748343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.87936387 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.17947949 |
| 3 | MP0008057_abnormal_DNA_replication | 3.42888499 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.37962613 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.14220604 |
| 6 | MP0005083_abnormal_biliary_tract | 2.95639836 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.80130222 |
| 8 | MP0009278_abnormal_bone_marrow | 2.72997543 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.62001581 |
| 10 | MP0009785_altered_susceptibility_to | 2.57020308 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.56181011 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.52699601 |
| 13 | * MP0002419_abnormal_innate_immunity | 2.50040125 |
| 14 | MP0002006_tumorigenesis | 2.48889169 |
| 15 | MP0003436_decreased_susceptibility_to | 2.48725627 |
| 16 | MP0003077_abnormal_cell_cycle | 2.44566391 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.43249333 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.41727031 |
| 19 | MP0000490_abnormal_crypts_of | 2.33410062 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.24015667 |
| 21 | MP0008058_abnormal_DNA_repair | 2.23879011 |
| 22 | * MP0005025_abnormal_response_to | 2.22886729 |
| 23 | MP0003724_increased_susceptibility_to | 2.20733505 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 2.14010892 |
| 25 | MP0003303_peritoneal_inflammation | 2.13983248 |
| 26 | MP0001545_abnormal_hematopoietic_system | 2.12574774 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 2.12574774 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.04944072 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 2.04088713 |
| 30 | MP0000858_altered_metastatic_potential | 1.98134383 |
| 31 | MP0006054_spinal_hemorrhage | 1.87630151 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.84051736 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.81432889 |
| 34 | MP0002009_preneoplasia | 1.80987076 |
| 35 | * MP0002420_abnormal_adaptive_immunity | 1.79756476 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.77968303 |
| 37 | MP0002398_abnormal_bone_marrow | 1.76732558 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.75978583 |
| 39 | * MP0001819_abnormal_immune_cell | 1.75446851 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.73912077 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.72269035 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.69548125 |
| 43 | MP0005671_abnormal_response_to | 1.60369391 |
| 44 | * MP0000716_abnormal_immune_system | 1.59915700 |
| 45 | * MP0005000_abnormal_immune_tolerance | 1.56989166 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.55258500 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.54232269 |
| 48 | MP0002095_abnormal_skin_pigmentation | 1.53062019 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.52788315 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.51692435 |
| 51 | MP0002722_abnormal_immune_system | 1.51565441 |
| 52 | MP0005220_abnormal_exocrine_pancreas | 1.50506561 |
| 53 | MP0004742_abnormal_vestibular_system | 1.50368496 |
| 54 | MP0001853_heart_inflammation | 1.50027400 |
| 55 | * MP0002429_abnormal_blood_cell | 1.49505543 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.49387578 |
| 57 | MP0000343_altered_response_to | 1.48623539 |
| 58 | MP0010307_abnormal_tumor_latency | 1.48526658 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.47378074 |
| 60 | MP0002723_abnormal_immune_serum | 1.47155418 |
| 61 | MP0001800_abnormal_humoral_immune | 1.41658772 |
| 62 | MP0003186_abnormal_redox_activity | 1.39217659 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.38418443 |
| 64 | MP0003866_abnormal_defecation | 1.35548880 |
| 65 | MP0008995_early_reproductive_senescence | 1.33154889 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.30627582 |
| 67 | * MP0001845_abnormal_inflammatory_respons | 1.29882503 |
| 68 | MP0002405_respiratory_system_inflammati | 1.28566335 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 1.27196874 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.23122250 |
| 71 | MP0003786_premature_aging | 1.22691098 |
| 72 | MP0004147_increased_porphyrin_level | 1.17865635 |
| 73 | MP0008932_abnormal_embryonic_tissue | 1.15620688 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.15557735 |
| 75 | MP0000685_abnormal_immune_system | 1.15401102 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.15252719 |
| 77 | MP0005360_urolithiasis | 1.15107718 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.13885978 |
| 79 | MP0001873_stomach_inflammation | 1.11698842 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.11646230 |
| 81 | MP0005670_abnormal_white_adipose | 1.10534275 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.09312447 |
| 83 | MP0001663_abnormal_digestive_system | 1.07430674 |
| 84 | MP0003300_gastrointestinal_ulcer | 1.07327907 |
| 85 | MP0000313_abnormal_cell_death | 1.05198233 |
| 86 | MP0000350_abnormal_cell_proliferation | 1.04914972 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 1.03982084 |
| 88 | MP0008469_abnormal_protein_level | 1.01240824 |
| 89 | MP0005409_darkened_coat_color | 0.98455838 |
| 90 | MP0001764_abnormal_homeostasis | 0.98127207 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.96242661 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.96026570 |
| 93 | MP0000358_abnormal_cell_content/ | 0.95995498 |
| 94 | MP0003075_altered_response_to | 0.94555595 |
| 95 | MP0006082_CNS_inflammation | 0.93707552 |
| 96 | MP0003828_pulmonary_edema | 0.93058656 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.91538338 |
| 98 | MP0002160_abnormal_reproductive_system | 0.88870479 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.88281630 |
| 100 | MP0003252_abnormal_bile_duct | 0.87854880 |
| 101 | MP0002822_catalepsy | 0.87245752 |
| 102 | MP0001730_embryonic_growth_arrest | 0.86177160 |
| 103 | MP0009115_abnormal_fat_cell | 0.85011549 |
| 104 | MP0000598_abnormal_liver_morphology | 0.84168488 |
| 105 | MP0009764_decreased_sensitivity_to | 0.82642567 |
| 106 | MP0003123_paternal_imprinting | 0.82392573 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.80993683 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.80181557 |
| 109 | MP0008260_abnormal_autophagy | 0.79886801 |
| 110 | MP0002970_abnormal_white_adipose | 0.79307098 |
| 111 | MP0001790_abnormal_immune_system | 0.78665648 |
| 112 | MP0005387_immune_system_phenotype | 0.78665648 |
| 113 | MP0000371_diluted_coat_color | 0.74668620 |
| 114 | MP0005334_abnormal_fat_pad | 0.72942152 |
| 115 | MP0002971_abnormal_brown_adipose | 0.71607154 |
| 116 | MP0001851_eye_inflammation | 0.70470484 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.70245048 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.69559398 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69109354 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.67000029 |
| 121 | MP0002075_abnormal_coat/hair_pigmentati | 0.66253014 |
| 122 | * MP0008873_increased_physiological_sensi | 0.65940074 |
| 123 | * MP0009763_increased_sensitivity_to | 0.65389531 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.65089315 |
| 125 | MP0003448_altered_tumor_morphology | 0.64039731 |
| 126 | MP0005384_cellular_phenotype | 0.63245273 |
| 127 | MP0002080_prenatal_lethality | 0.60872646 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.59013974 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.58384272 |
| 130 | MP0001186_pigmentation_phenotype | 0.57627775 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.54862126 |
| 132 | MP0002083_premature_death | 0.54489693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 7.89290109 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.89676776 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.63973219 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47548663 |
| 5 | Abnormality of the prostate (HP:0008775) | 4.45675118 |
| 6 | Reduced antithrombin III activity (HP:0001976) | 4.37359060 |
| 7 | Aplastic anemia (HP:0001915) | 4.26822804 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 4.11165240 |
| 9 | Obstructive lung disease (HP:0006536) | 4.08604640 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.08604640 |
| 11 | Acute lymphatic leukemia (HP:0006721) | 3.91243574 |
| 12 | Papilledema (HP:0001085) | 3.89400707 |
| 13 | Reticulocytopenia (HP:0001896) | 3.81851437 |
| 14 | Chest pain (HP:0100749) | 3.68920535 |
| 15 | Myositis (HP:0100614) | 3.62698088 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.62065763 |
| 17 | Periodontitis (HP:0000704) | 3.54288025 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.51656284 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.48405157 |
| 20 | Eosinophilia (HP:0001880) | 3.42473176 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.40044943 |
| 22 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.40044943 |
| 23 | Abnormal protein glycosylation (HP:0012346) | 3.40044943 |
| 24 | Abnormal glycosylation (HP:0012345) | 3.40044943 |
| 25 | Granulocytopenia (HP:0001913) | 3.33048300 |
| 26 | Pulmonary fibrosis (HP:0002206) | 3.24067552 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.16768254 |
| 28 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.10336539 |
| 29 | Oral leukoplakia (HP:0002745) | 2.98123346 |
| 30 | Hepatosplenomegaly (HP:0001433) | 2.96190574 |
| 31 | Meningitis (HP:0001287) | 2.95549822 |
| 32 | IgM deficiency (HP:0002850) | 2.92139147 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.84420904 |
| 34 | Ureteral stenosis (HP:0000071) | 2.84398205 |
| 35 | Petechiae (HP:0000967) | 2.81275830 |
| 36 | Amyloidosis (HP:0011034) | 2.75624390 |
| 37 | Chronic otitis media (HP:0000389) | 2.75075603 |
| 38 | Chromsome breakage (HP:0040012) | 2.69411266 |
| 39 | Spondylolisthesis (HP:0003302) | 2.67697503 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62990717 |
| 41 | Abnormality of the pleura (HP:0002103) | 2.61223898 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.58760724 |
| 43 | B lymphocytopenia (HP:0010976) | 2.58760724 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.56297526 |
| 45 | Gangrene (HP:0100758) | 2.56284159 |
| 46 | Hemoptysis (HP:0002105) | 2.56171931 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.55751517 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.54187820 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.53039663 |
| 50 | 11 pairs of ribs (HP:0000878) | 2.51513591 |
| 51 | Neutropenia (HP:0001875) | 2.50921139 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50399970 |
| 53 | Abnormality of the lumbar spine (HP:0100712) | 2.50072454 |
| 54 | Abnormality of eosinophils (HP:0001879) | 2.49123188 |
| 55 | Cellulitis (HP:0100658) | 2.48218949 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.48132393 |
| 57 | Ureteral obstruction (HP:0006000) | 2.46196662 |
| 58 | Pulmonary embolism (HP:0002204) | 2.42381963 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.41301521 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40927946 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40927946 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.39805721 |
| 63 | Epistaxis (HP:0000421) | 2.39071481 |
| 64 | Hepatic necrosis (HP:0002605) | 2.37009243 |
| 65 | Agnosia (HP:0010524) | 2.36532759 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.30008553 |
| 67 | Poikiloderma (HP:0001029) | 2.28939275 |
| 68 | Myelodysplasia (HP:0002863) | 2.28422785 |
| 69 | Pancytopenia (HP:0001876) | 2.28255307 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.27717630 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.27342267 |
| 72 | Bone marrow hypocellularity (HP:0005528) | 2.27027358 |
| 73 | Abnormality of the thoracic spine (HP:0100711) | 2.23702508 |
| 74 | Birth length less than 3rd percentile (HP:0003561) | 2.23613472 |
| 75 | Poor head control (HP:0002421) | 2.23318016 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22113468 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22113468 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22113468 |
| 79 | Paresthesia (HP:0003401) | 2.21233127 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.20558140 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.20521090 |
| 82 | Leukocytosis (HP:0001974) | 2.20091767 |
| 83 | Macrocytic anemia (HP:0001972) | 2.18158755 |
| 84 | Recurrent viral infections (HP:0004429) | 2.17916530 |
| 85 | Severe visual impairment (HP:0001141) | 2.16854284 |
| 86 | Generalized aminoaciduria (HP:0002909) | 2.15946991 |
| 87 | Fatigue (HP:0012378) | 2.15547134 |
| 88 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.15130297 |
| 89 | Abnormality of male internal genitalia (HP:0000022) | 2.14451318 |
| 90 | Osteomyelitis (HP:0002754) | 2.14230675 |
| 91 | Amaurosis fugax (HP:0100576) | 2.12927848 |
| 92 | Recurrent skin infections (HP:0001581) | 2.11241870 |
| 93 | Increased serum ferritin (HP:0003281) | 2.10144217 |
| 94 | Vasculitis (HP:0002633) | 2.09980259 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 2.09643672 |
| 96 | Abnormal platelet function (HP:0011869) | 2.07115413 |
| 97 | Impaired platelet aggregation (HP:0003540) | 2.07115413 |
| 98 | Abnormality of chromosome stability (HP:0003220) | 2.07017382 |
| 99 | Stomatitis (HP:0010280) | 2.06218996 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04840829 |
| 101 | Hepatocellular necrosis (HP:0001404) | 2.02302908 |
| 102 | Thrombophlebitis (HP:0004418) | 2.01314615 |
| 103 | Abnormality of the anterior horn cell (HP:0006802) | 2.01276955 |
| 104 | Degeneration of anterior horn cells (HP:0002398) | 2.01276955 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00439227 |
| 106 | Skin ulcer (HP:0200042) | 1.98511140 |
| 107 | Skin rash (HP:0000988) | 1.98455193 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.97970115 |
| 109 | Orchitis (HP:0100796) | 1.97630522 |
| 110 | Acute myeloid leukemia (HP:0004808) | 1.97352325 |
| 111 | Premature graying of hair (HP:0002216) | 1.97325191 |
| 112 | Progressive muscle weakness (HP:0003323) | 1.97105804 |
| 113 | Thoracic kyphosis (HP:0002942) | 1.96791158 |
| 114 | Pallor (HP:0000980) | 1.94853912 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 1.94782211 |
| 116 | Rhabdomyolysis (HP:0003201) | 1.93596912 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.93494985 |
| 118 | Multiple enchondromatosis (HP:0005701) | 1.93208812 |
| 119 | Increased hepatocellular lipid droplets (HP:0006565) | 1.91697169 |
| 120 | Sepsis (HP:0100806) | 1.91444370 |
| 121 | Restrictive lung disease (HP:0002091) | 1.90927428 |
| 122 | Abnormality of the pericardium (HP:0001697) | 1.90699791 |
| 123 | Abnormality of the preputium (HP:0100587) | 1.90233382 |
| 124 | Lymphoma (HP:0002665) | 1.88513295 |
| 125 | Microcytic anemia (HP:0001935) | 1.88359031 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88025900 |
| 127 | Urticaria (HP:0001025) | 1.85824620 |
| 128 | Arterial thrombosis (HP:0004420) | 1.85748305 |
| 129 | Abnormality of DNA repair (HP:0003254) | 1.82656243 |
| 130 | Glomerulopathy (HP:0100820) | 1.82317464 |
| 131 | Thickened calvaria (HP:0002684) | 1.81522379 |
| 132 | Increased serum lactate (HP:0002151) | 1.81465103 |
| 133 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81463794 |
| 134 | Exertional dyspnea (HP:0002875) | 1.81444848 |
| 135 | Albinism (HP:0001022) | 1.80173352 |
| 136 | Polyneuropathy (HP:0001271) | 1.79965345 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.78101382 |
| 138 | Cutaneous melanoma (HP:0012056) | 1.78063998 |
| 139 | Increased muscle lipid content (HP:0009058) | 1.77824170 |
| 140 | Abdominal pain (HP:0002027) | 1.77775559 |
| 141 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77410070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.90444735 |
| 2 | EIF2AK3 | 3.09366045 |
| 3 | IRAK4 | 2.98697097 |
| 4 | TEC | 2.89072013 |
| 5 | VRK2 | 2.77054811 |
| 6 | MAP3K12 | 2.72014087 |
| 7 | WEE1 | 2.71080903 |
| 8 | PIM2 | 2.53895482 |
| 9 | CDC7 | 2.51467217 |
| 10 | VRK1 | 2.32768368 |
| 11 | BUB1 | 2.27039362 |
| 12 | EIF2AK1 | 2.22259604 |
| 13 | TAOK3 | 2.18871512 |
| 14 | BTK | 2.15293296 |
| 15 | SCYL2 | 2.12925562 |
| 16 | TNK2 | 2.10828833 |
| 17 | CDK12 | 1.93493225 |
| 18 | MAP2K3 | 1.88090651 |
| 19 | CDK6 | 1.79048212 |
| 20 | BLK | 1.76073859 |
| 21 | KIT | 1.70528195 |
| 22 | ERN1 | 1.66258019 |
| 23 | FES | 1.63058261 |
| 24 | DAPK1 | 1.56371392 |
| 25 | TSSK6 | 1.55381356 |
| 26 | SRPK1 | 1.54847964 |
| 27 | NUAK1 | 1.54574295 |
| 28 | SMG1 | 1.54473964 |
| 29 | EEF2K | 1.53925141 |
| 30 | MAP3K6 | 1.53142949 |
| 31 | FLT3 | 1.48661414 |
| 32 | TESK1 | 1.47621586 |
| 33 | TESK2 | 1.46176004 |
| 34 | ICK | 1.41995798 |
| 35 | ATR | 1.37214188 |
| 36 | CAMK1D | 1.36858374 |
| 37 | PRPF4B | 1.36564087 |
| 38 | BRSK2 | 1.33985849 |
| 39 | CDK7 | 1.33939839 |
| 40 | MAP4K1 | 1.30508855 |
| 41 | CLK1 | 1.27699672 |
| 42 | CDK8 | 1.25741088 |
| 43 | TNIK | 1.24285678 |
| 44 | PAK4 | 1.17730809 |
| 45 | ABL2 | 1.16977130 |
| 46 | BMPR2 | 1.15043597 |
| 47 | ITK | 1.11923746 |
| 48 | RPS6KB2 | 1.10596442 |
| 49 | MKNK1 | 1.10345697 |
| 50 | HIPK2 | 1.08999463 |
| 51 | PASK | 1.08736101 |
| 52 | MYLK | 1.08661996 |
| 53 | TBK1 | 1.08335957 |
| 54 | SYK | 1.06453528 |
| 55 | NEK2 | 1.04303230 |
| 56 | NME2 | 1.03335092 |
| 57 | ZAP70 | 0.98501961 |
| 58 | PKN2 | 0.95109730 |
| 59 | HCK | 0.92214606 |
| 60 | BRD4 | 0.91440112 |
| 61 | AURKB | 0.89702143 |
| 62 | ACVR1B | 0.88863979 |
| 63 | CDK19 | 0.88682423 |
| 64 | EIF2AK2 | 0.87567605 |
| 65 | IRAK3 | 0.86435641 |
| 66 | PLK4 | 0.85565262 |
| 67 | RPS6KC1 | 0.84255360 |
| 68 | RPS6KL1 | 0.84255360 |
| 69 | MAPK4 | 0.83056399 |
| 70 | RPS6KA6 | 0.80784155 |
| 71 | TRIB3 | 0.80682714 |
| 72 | RAF1 | 0.80391280 |
| 73 | TLK1 | 0.80064942 |
| 74 | RPS6KB1 | 0.79546036 |
| 75 | MAP3K8 | 0.78997170 |
| 76 | NEK1 | 0.78573184 |
| 77 | TGFBR1 | 0.78028902 |
| 78 | CAMK1G | 0.77497862 |
| 79 | CDK4 | 0.77488320 |
| 80 | PLK1 | 0.77184233 |
| 81 | MATK | 0.77056408 |
| 82 | LIMK1 | 0.76415475 |
| 83 | IKBKB | 0.75495777 |
| 84 | CCNB1 | 0.74594028 |
| 85 | LYN | 0.73663289 |
| 86 | DYRK3 | 0.72343273 |
| 87 | TYK2 | 0.70591500 |
| 88 | MKNK2 | 0.70052185 |
| 89 | PIM1 | 0.69108597 |
| 90 | BCKDK | 0.69017234 |
| 91 | BRSK1 | 0.67534600 |
| 92 | KDR | 0.66793471 |
| 93 | LCK | 0.66079709 |
| 94 | ILK | 0.65629728 |
| 95 | LRRK2 | 0.64710653 |
| 96 | MAPKAPK3 | 0.63788996 |
| 97 | CAMKK2 | 0.63650029 |
| 98 | TTK | 0.63454355 |
| 99 | RPS6KA2 | 0.62622792 |
| 100 | MAPK11 | 0.62211511 |
| 101 | IKBKE | 0.61027291 |
| 102 | STK4 | 0.60768391 |
| 103 | RPS6KA4 | 0.60033375 |
| 104 | TRPM7 | 0.58523689 |
| 105 | GRK7 | 0.58129085 |
| 106 | PIK3CG | 0.57412435 |
| 107 | RIPK4 | 0.55750442 |
| 108 | MAP3K14 | 0.55559133 |
| 109 | MAPKAPK5 | 0.54909579 |
| 110 | CSF1R | 0.54415604 |
| 111 | PLK3 | 0.53073850 |
| 112 | CSNK2A2 | 0.49600410 |
| 113 | GRK6 | 0.49560212 |
| 114 | TXK | 0.47684770 |
| 115 | CHEK2 | 0.47441090 |
| 116 | CSNK2A1 | 0.47182434 |
| 117 | PAK1 | 0.46859817 |
| 118 | CHEK1 | 0.44496105 |
| 119 | PAK2 | 0.43948492 |
| 120 | STK10 | 0.43214883 |
| 121 | MAP3K11 | 0.43078318 |
| 122 | ZAK | 0.42945159 |
| 123 | MAP2K6 | 0.41850255 |
| 124 | MAP3K10 | 0.39556088 |
| 125 | MAP2K2 | 0.39437237 |
| 126 | CDK2 | 0.38972529 |
| 127 | TAOK2 | 0.37150761 |
| 128 | MTOR | 0.37108880 |
| 129 | RET | 0.37108327 |
| 130 | JAK3 | 0.36432285 |
| 131 | TAF1 | 0.35497377 |
| 132 | JAK2 | 0.33710022 |
| 133 | MAP2K4 | 0.33663728 |
| 134 | CDK3 | 0.33304519 |
| 135 | PRKAA2 | 0.33299343 |
| 136 | MARK2 | 0.32773269 |
| 137 | CDK9 | 0.31830261 |
| 138 | MAPK3 | 0.31799673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.57778498 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.85310544 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.41024590 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.18245715 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 3.14399412 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 3.09116840 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64011194 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.44452495 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.29503996 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.26465206 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.18559237 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.15349589 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.11505880 |
| 14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.03884542 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.03001135 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98416205 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.97078419 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90855362 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.79523829 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.70658167 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63295043 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.62789214 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.55587330 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53669654 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46513270 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41459160 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37031628 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.32797451 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32305663 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29244285 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22863873 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21868859 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18712224 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13191110 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12991470 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.11877001 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10867317 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10391318 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.09539594 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01814933 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.00654814 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 0.98475345 |
| 43 | Asthma_Homo sapiens_hsa05310 | 0.98344089 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.98280421 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97927312 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97887799 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97875746 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96630973 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92645991 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86862002 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86255269 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85579195 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85508044 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85262495 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.84787919 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84144566 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83394582 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82211411 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80505925 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78017478 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76934297 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74994613 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74356396 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71820419 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71628684 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70974155 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69473066 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67653239 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66997529 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.63419315 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60376317 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60118934 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56976685 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56589025 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.56556812 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55725563 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54840290 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54469453 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53652909 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52549842 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51413811 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50837098 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.50219028 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49745973 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46905342 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46380138 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.45718423 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43768741 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43689876 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43322479 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.41711270 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41316521 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41072485 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40391533 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39823822 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38917835 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38419383 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.36962555 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36709701 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.35531011 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.34900650 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34862183 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34304100 |
| 104 | * Phagosome_Homo sapiens_hsa04145 | 0.33936676 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33564066 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32103492 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31468770 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31030092 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30746655 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.30669756 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.30635935 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30240718 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30237404 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.29817991 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29622787 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29549184 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28971078 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27674084 |
| 119 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26947423 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26406315 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.25306033 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25263102 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24662390 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24528057 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24293008 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24244227 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23205015 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22383726 |

